Professor of Rheumatology, University of Oslo, and Head of the Department of Rheumatology at Diakonhjemmet Hospital of Oslo, Norway
Important and relevant publications:
- The changing landscape of biosimilars in rheumatology – Thomas Dörner,Vibeke Strand, Paul Cornes, João Gonçalves, László Gulácsi, Jonathan Kay, Tore K Kvien, Josef Smolen, Yoshiya Tanaka, Gerd R Burmester
- Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study – Won Park, Dae Hyun Yoo, Pedro Miranda, Marek Brzosko, Piotr Wiland, Sergio Gutierrez-Ureña, Helena Mikazane, Yeon-Ah Lee, Svitlana Smiyan, Mie-Jin Lim, Vladimir Kadinov, Carlos Abud-Mendoza, HoUng Kim, Sang Joon Lee, YunJu Bae, SuYeon Kim, Jürgen Braun
- Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparisonbetween switching from reference infliximab toCT-P13 and continuing CT-P13 in the PLANETRA extension study – Dae Hyun Yoo, Nenad Prodanovic, Janusz Jaworski, Pedro Miranda,4Edgar Ramiterre, Allan Lanzon, Asta Baranauskaite, Piotr Wiland, Carlos Abud-Mendoza, Boycho Oparanov, Svitlana Smiyan, HoUng Kim, Sang Joon Lee, SuYeon Kim, Won Park
- NOR-SWITCH poster
Volg ons via: